mabl is an AI-powered test automation platform that simplifies end-to-end testing for web applications. It uses AI to accelerate test creation, execution, and maintenance, enabling agile and DevOps teams to deliver high-quality software faster. With features like self-healing tests and AI-driven root cause analysis, mabl reduces the effort of maintaining brittle test suites.
PerfAgents is an AI-powered synthetic monitoring platform designed for QA and DevOps teams. It leverages existing test scripts from frameworks like Playwright, Selenium, and Cypress, or generates new ones using natural language to continuously monitor website and API performance, availability, and critical user flows from global locations.
mabl is an AI-powered test automation platform that simplifies end-to-end testing for web applications. It uses AI to accelerate test creation, execution, and maintenance, enabling agile and DevOps teams to deliver high-quality software faster. With features like self-healing tests and AI-driven root cause analysis, mabl reduces the effort of maintaining brittle test suites.
PerfAgents is an AI-powered synthetic monitoring platform designed for QA and DevOps teams. It leverages existing test scripts from frameworks like Playwright, Selenium, and Cypress, or generates new ones using natural language to continuously monitor website and API performance, availability, and critical user flows from global locations.
| Feature | mabl | PerfAgents |
|---|---|---|
| Primary category | Testing | Monitoring |
| Added | 2025-08-10 | 2025-08-01 |
| Pricing | Paid | Freemium |
| Official website | www.mabl.com | www.perfagents.com |
| Product type | Website | Website |
| Performance data | ||
| User rating | Not verified | Not verified |
| Comments | 0 | 0 |
| Monthly visits | 108.5K | 42 |
| Monthly growth | -8.7% | -87.1% |
| Favorites | 128 | 116 |
| Details | View details | View details |
Compare mabl and PerfAgents by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
In the mabl vs PerfAgents monthly traffic comparison, mabl currently shows 108.5K visits and PerfAgents shows 42; mabl has about 2,583.7 times the visible traffic of PerfAgents, an absolute difference of about 108.5K visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇯🇵Japan | 35.25% | 38.3K |
| 🇺🇸United States | 25.96% | 28.2K |
| 🇮🇳India | 20.4% | 22.1K |
| 🇬🇧United Kingdom | 13.55% | 14.7K |
| 🇳🇬Nigeria | 4.84% | 5.3K |
| Source type | Percentage | Traffic |
|---|---|---|
| Direct | 95.03% | 103.1K |
| Referral | 2.83% | 3.1K |
| 2.14% | 2.3K |
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇵🇹Portugal | 100% | 42 |
This in-depth mabl vs PerfAgents comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. mabl is primarily listed under “Testing”, while PerfAgents is primarily listed under “Monitoring”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (mabl: Testing; PerfAgents: Monitoring); Pricing (mabl: Paid; PerfAgents: Freemium); Monthly visits (mabl: 108.5K; PerfAgents: 42); Monthly growth (mabl: -8.7%; PerfAgents: -87.1%); Favorites (mabl: 128; PerfAgents: 116). These facts are more useful for selection than brand visibility alone.
In the mabl vs PerfAgents monthly traffic comparison, mabl currently shows 108.5K visits and PerfAgents shows 42; mabl has about 2,583.7 times the visible traffic of PerfAgents, an absolute difference of about 108.5K visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
If public market visibility is an important first-pass criterion, investigate mabl first. The final choice should still follow taxonomy, use case, and a real trial because higher traffic does not prove broader capabilities or better workflow fit.
mabl and PerfAgents currently overlap in shared categories: Testing and Automation; shared tags: devops. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
mabl's unique categories/tags are Continuous Integration, ai testing, CI/CD, end-to-end testing, low-code, Q&A, regression testing, and self-healing tests; PerfAgents's are Monitoring, AI script generation, API monitoring, continuous testing, cypress, performance testing, Playwright, and qa testing. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
mabl has no verified rating, 0 comments, 128 favorites, and 114 likes；PerfAgents has no verified rating, 0 comments, 116 favorites, and 113 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Put mabl on the priority trial list when the task aligns with “Testing” and especially Continuous Integration, ai testing, CI/CD, end-to-end testing, low-code, and Q&A. This follows recorded positioning and does not imply unlisted capabilities are absent.
mabl also currently records: pricing is paid, product type is website, 108.5K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
Put PerfAgents on the priority trial list when the task aligns with “Monitoring” and especially Monitoring, AI script generation, API monitoring, continuous testing, cypress, and performance testing. This follows recorded positioning and does not imply unlisted capabilities are absent.
PerfAgents also currently records: pricing is freemium, product type is website, 42 verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in mabl and PerfAgents, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.
